TY - JOUR
T1 - Hydrogen Gas Inhalation Attenuates Endothelial Glycocalyx Damage and Stabilizes Hemodynamics in a Rat Hemorrhagic Shock Model
AU - Tamura, Tomoyoshi
AU - Sano, Motoaki
AU - Matsuoka, Tadashi
AU - Yoshizawa, Joe
AU - Yamamoto, Ryo
AU - Katsumata, Yoshinori
AU - Endo, Jin
AU - Homma, Koichiro
AU - Kajimura, Mayumi
AU - Suzuki, Masaru
AU - Kobayashi, Eiji
AU - Sasaki, Junichi
N1 - Funding Information:
The research was supported by a research grant from Taiyo Nippon Sanso Corporation to MSa, and xanthine oxidoreductase inhibitor (Topiroxat) was provided by Sanwa Kagaku Kenkyusho Co, Ltd. TT, MSa, and MSu received a travel grant from the Taiyo Nippon Sanso Corporation.
Publisher Copyright:
© 2020 Lippincott Williams and Wilkins. All rights reserved.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Background:Hydrogen gas (H2) inhalation during hemorrhage stabilizes post-resuscitation hemodynamics, improving short-Term survival in a rat hemorrhagic shock and resuscitation (HS/R) model. However, the underlying molecular mechanism of H2in HS/R is unclear. Endothelial glycocalyx (EG) damage causes hemodynamic failure associated with HS/R. In this study, we tested the hypothesis that H2alleviates oxidative stress by suppressing xanthine oxidoreductase (XOR) and/or preventing tumor necrosis factor-Alfa (TNF-α)-mediated syndecan-1 shedding during EG damage.Methods:HS/R was induced in rats by reducing mean arterial pressure (MAP) to 35mm Hg for 60min followed by resuscitation. Rats inhaled oxygen or H2+ oxygen after achieving shock either in the presence or absence of an XOR inhibitor (XOR-I) for both the groups. In a second test, rats received oxygen alone or antitumor necrosis factor (TNF)-α monoclonal antibody with oxygen or H2. Two hours after resuscitation, XOR activity, purine metabolites, cytokines, syndecan-1 were measured and survival rates were assessed 6h after resuscitation.Results:H2and XOR-I both suppressed MAP reduction and improved survival rates. H2did not affect XOR activity and the therapeutic effects of XOR-I and H2were additive. H2suppressed plasma TNF-α and syndecan-1 expression; however, no additional H2therapeutic effect was observed in the presence of anti-TNF-α monoclonal antibody.Conclusions:H2inhalation after shock stabilized hemodynamics and improved survival rates in an HS/R model independent of XOR. The therapeutic action of H2was partially mediated by inhibition of TNF-α-dependent syndecan-1 shedding.
AB - Background:Hydrogen gas (H2) inhalation during hemorrhage stabilizes post-resuscitation hemodynamics, improving short-Term survival in a rat hemorrhagic shock and resuscitation (HS/R) model. However, the underlying molecular mechanism of H2in HS/R is unclear. Endothelial glycocalyx (EG) damage causes hemodynamic failure associated with HS/R. In this study, we tested the hypothesis that H2alleviates oxidative stress by suppressing xanthine oxidoreductase (XOR) and/or preventing tumor necrosis factor-Alfa (TNF-α)-mediated syndecan-1 shedding during EG damage.Methods:HS/R was induced in rats by reducing mean arterial pressure (MAP) to 35mm Hg for 60min followed by resuscitation. Rats inhaled oxygen or H2+ oxygen after achieving shock either in the presence or absence of an XOR inhibitor (XOR-I) for both the groups. In a second test, rats received oxygen alone or antitumor necrosis factor (TNF)-α monoclonal antibody with oxygen or H2. Two hours after resuscitation, XOR activity, purine metabolites, cytokines, syndecan-1 were measured and survival rates were assessed 6h after resuscitation.Results:H2and XOR-I both suppressed MAP reduction and improved survival rates. H2did not affect XOR activity and the therapeutic effects of XOR-I and H2were additive. H2suppressed plasma TNF-α and syndecan-1 expression; however, no additional H2therapeutic effect was observed in the presence of anti-TNF-α monoclonal antibody.Conclusions:H2inhalation after shock stabilized hemodynamics and improved survival rates in an HS/R model independent of XOR. The therapeutic action of H2was partially mediated by inhibition of TNF-α-dependent syndecan-1 shedding.
KW - Fluid resuscitation
KW - TNF-α
KW - molecular hydrogen
KW - syndecan-1
KW - vascular permeability
KW - xanthine oxidoreductase
UR - http://www.scopus.com/inward/record.url?scp=85087375297&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087375297&partnerID=8YFLogxK
U2 - 10.1097/SHK.0000000000001459
DO - 10.1097/SHK.0000000000001459
M3 - Article
C2 - 32804466
AN - SCOPUS:85087375297
SN - 1073-2322
VL - 54
SP - 377
EP - 385
JO - Shock
JF - Shock
IS - 3
ER -